AI Article Synopsis
- Robotic surgery for removing parts of the pancreas has become more popular because it's less invasive than traditional methods, which can be risky.
- In a study done in Australia, 62 patients had robotic pancreas surgery between 2014 and 2020, and they were mostly older adults.
- The results showed that while some patients had complications, the robotic surgery was safe, and it might lead to better recovery for patients in the future.
Article Abstract
Background: Minimally invasive pancreatic resection has been gathering interest over the last decade due to the technical demands and high morbidity associated with these typically open procedures. We report our experience with robotic pancreatectomy within an Australian context.
Methods: All patients undergoing robotic distal pancreatectomy (DP) and pancreaticoduodenectomy (PD) at two Australian tertiary academic hospitals between May 2014 and December 2020 were included.
Results: Sixty-two patients underwent robotic pancreatectomy during the study period. Thirty-four patients with a median age of 68 years (range 42-84) were in the PD group whilst the DP group included 28 patients with a median age of 60 years (range 18-78). Thirteen patients (46.4%) in the DP group had spleen-preserving procedures. There were 13 conversions (38.2%) in the PD group whilst 0 conversions occurred in the DP group. The Clavien-Dindo grade ≥III complication rate was 26.4% and 17.9% in the PD and DP groups, respectively. Two deaths (5.9%) occurred within 90-days in the PD group whilst none were observed in the DP group. The median length of hospital stay was 11.5 days (range 4-56) in the PD group and 6 days (range 2-22) in the DP group.
Conclusion: Robotic pancreatectomy outcomes at our institution are comparable with international literature demonstrating it is both safe and feasible to perform. With improved access to this platform, robotic pancreas surgery may prove to be the turning point for patients with regards to post-operative complications as more experience is obtained.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ans.18998 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robotic Versus Open Distal Pancreatectomy: A Propensity Score Matching Analysis.
Int J Med Robot
December 2024
Hepato-Biliary-Pancreatic Surgery Division, Florence, Italy.
Background: Minimally invasive distal pancreatectomy offers recognised benefits over open surgery. Robotic surgery, with its shorter learning curve and technical advancements, presents a promising alternative to laparoscopy in managing pancreatic diseases.
Methods: This study enrolled consecutive patients undergoing distal pancreatectomy between January 2013 and May 2022.
External Validation of the ISGPS Complexity Grading System for Minimally Invasive Pancreatoduodenectomy: Insights from the IGOMIPS registry.
Ann Surg
December 2024
Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Objective: To validate the ISGPS complexity grading system for minimally invasive pancreaticoduodenectomy (MIPD).
Background: Although concerns about patient safety persist, MIPD is gaining popularity. The ISGPS recently introduced a difficulty grading system to improve patient selection by aligning procedural complexity with surgeon and center expertise.
ArtiSential-assisted laparoscopic central pancreatectomy.
J Minim Invasive Surg
December 2024
Department of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul, Korea.
Central pancreatectomy (CP) is a viable option for low malignant tumors located in the neck or proximal body of the pancreas. This procedure has the advantage of minimizing impairment to pancreatic function. However, it is technically challenging and carries a relatively high risk of postoperative pancreatic fistula.
View Article and Find Full Text PDFOncologic Efficacy of Robotic Compared to Open Total Pancreatectomy for Pancreatic Cancer.
J Surg Res
December 2024
Department of Surgery, University of Florida College of Medicine, Gainesville, Florida.
Article Synopsis
- The study examines the effectiveness and feasibility of robotic total pancreatectomy (RTP) compared to open total pancreatectomy (OTP) for pancreatic cancer, highlighting a shift towards more robotic surgeries over time.
- Analyzed data from 188 RTP and 3,447 OTP patients from 2010 to 2019 found no significant differences in outcomes such as mortality rates and oncological effectiveness, but RTP patients experienced a shorter hospital stay.
- Overall survival rates were similar for both methods, suggesting that RTP is a viable option for pancreatic cancer surgery without compromising patient outcomes.
Robotic versus open pancreatoduodenectomy for periampullary neoplasm: a propensity matched analysis of peri-operative and oncologic outcomes.
Surg Endosc
December 2024
Department of Community Medicine, ESIC Medical College and Hospital, Faridabad, Haryana, India.
Introduction: Though open pancreatoduodenectomy (OPD) is the gold standard, robotic pancreatoduodenectomy (RPD) is on the rise due to its technical ease with robotic armamentarium and claim to decrease morbidity in the perioperative period. This study compares the perioperative and oncologic outcomes of RPD performed for periampullary neoplasms (PANs) with OPD.
Method: This is a retrospective study conducted from January 2018 to December 2023 for all the patients who underwent either OPD or RPD for PANs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!